Acutaas Chemicals · NSE: ACUTAAS · BSE: 543349
Q1 FY26 results · Apr–Jun 2025
Acutaas Chemicals reported revenue from operations of ₹207.24 crore (up 17.3% from Q1 FY25) and net profit of ₹44.01 crore (up 199.6% from Q1 FY25) for Q1 FY26 (Apr–Jun 2025), on a consolidated basis.
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 207.24 | 176.67 | +17.3% | 308.48 | −32.8% |
| Other income | 15.94 | 1.04 | 15x | 5.78 | +175.8% |
| Total income | 223.17 | 177.71 | +25.6% | 314.26 | −29.0% |
| Profit before tax | 58.08 | 19.95 | +191.0% | 82.83 | −29.9% |
| Net profit for the period | 44.01 | 14.69 | +199.6% | 62.72 | −29.8% |
| Attributable to shareholders of the company | 44.29 | 13.95 | +217.6% | 62.48 | −29.1% |
| EPS, basic (₹) | 5.41 | 3.67 | not comparable | 7.80 | −30.6% |
| Net margin (%) | 21.2 | 8.3 | 20.3 |
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 205.97 | 171.14 | +20.4% | 304.16 | −32.3% |
| Other income | 16.02 | 1.90 | +744.4% | 5.69 | +181.3% |
| Total income | 221.99 | 173.03 | +28.3% | 309.86 | −28.4% |
| Profit before tax | 58.93 | 18.20 | +223.8% | 82.81 | −28.8% |
| Net profit for the period | 44.65 | 13.72 | +225.5% | 62.85 | −29.0% |
| EPS, basic (₹) | 5.45 | 3.43 | not comparable | 7.84 | −30.5% |
| Net margin (%) | 21.7 | 8.0 | 20.7 |
Consolidated
- Filed with BSE
- 30 Jul 2025, 16:48 IST
- Board meeting
- 30 Jul 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 30 Jul 2025, 16:48 IST
- Board meeting
- 30 Jul 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE